Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Truncated FGFR2 is a clinically actionable oncogene in multiple cancers
Authors
Keywords
-
Journal
NATURE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-11
DOI
10.1038/s41586-022-05066-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- FIGHT-101, a first-in-human study of potent and selective FGFR 1–3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies
- (2022) V. Subbiah et al. ANNALS OF ONCOLOGY
- Robust inference of kinase activity using functional networks
- (2021) Serhan Yılmaz et al. Nature Communications
- PPIDomainMiner: Inferring domain-domain interactions from multiple sources of protein-protein interactions
- (2021) Seyed Ziaeddin Alborzi et al. PLoS Computational Biology
- Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling
- (2021) Patrycja Szybowska et al. Cells
- Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer
- (2021) Ikuko Takeda Nakamura et al. npj Precision Oncology
- High FGFR1–4 mRNA Expression Levels Correlate with Response to Selective FGFR Inhibitors in Breast Cancer
- (2021) Mònica Sánchez-Guixé et al. CLINICAL CANCER RESEARCH
- ecDNA hubs drive cooperative intermolecular oncogene expression
- (2021) King L. Hung et al. NATURE
- Patterns of somatic structural variation in human cancer genomes
- (2020) Yilong Li et al. NATURE
- Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W
- (2020) Young K. Chae et al. JOURNAL OF CLINICAL ONCOLOGY
- Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
- (2020) Ghassan K Abou-Alfa et al. LANCET ONCOLOGY
- INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models
- (2020) Phillip C. C. Liu et al. PLoS One
- Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancer
- (2019) Stefano Annunziato et al. Nature Communications
- Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer
- (2019) Luigi Formisano et al. Nature Communications
- A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations
- (2019) Martin H. Voss et al. CLINICAL CANCER RESEARCH
- INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases
- (2019) Robin Beekhof et al. Molecular Systems Biology
- Next-generation characterization of the Cancer Cell Line Encyclopedia
- (2019) Mahmoud Ghandi et al. NATURE
- Cancer Mutations in FGFR2 Prevent a Negative Feedback Loop Mediated by the ERK1/2 Pathway
- (2019) Patrycja Szybowska et al. Cells
- Tumor Heterogeneity Underlies Differential Cisplatin Sensitivity in Mouse Models of Small-Cell Lung Cancer
- (2019) Franziska Böttger et al. Cell Reports
- Pan-cancer whole-genome analyses of metastatic solid tumours
- (2019) Peter Priestley et al. NATURE
- Rebalancing of actomyosin contractility enables mammary tumor formation upon loss of E-cadherin
- (2019) Koen Schipper et al. Nature Communications
- Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality
- (2018) Ewa Gogola et al. CANCER CELL
- EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation
- (2018) Daniel Zingg et al. CANCER CELL
- Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma
- (2018) Milind Javle et al. JOURNAL OF CLINICAL ONCOLOGY
- Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA
- (2018) Travis A. Clark et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Crystal Structure of Bicc1 SAM Polymer and Mapping of Interactions between the Ciliopathy-Associated Proteins Bicc1, ANKS3, and ANKS6
- (2018) Benjamin Rothé et al. STRUCTURE
- Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
- (2018) Qingsong Gao et al. Cell Reports
- Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547
- (2018) Sjors M. Kas et al. CANCER RESEARCH
- Detection of known and novel FGFR fusions in non-small cell lung cancer by comprehensive genomic profiling
- (2018) Angel Qin et al. Journal of Thoracic Oncology
- A curated resource for phosphosite-specific signature analysis
- (2018) Karsten Krug et al. MOLECULAR & CELLULAR PROTEOMICS
- Fibroblast growth factor receptors as treatment targets in clinical oncology
- (2018) Masaru Katoh Nature Reviews Clinical Oncology
- The PRIDE database and related tools and resources in 2019: improving support for quantification data
- (2018) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly
- (2017) Daniel L. Cameron et al. GENOME RESEARCH
- Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinoma
- (2017) Sjors M Kas et al. NATURE GENETICS
- Annotation-free quantification of RNA splicing using LeafCutter
- (2017) Yang I. Li et al. NATURE GENETICS
- Identifying transposon insertions and their effects from RNA-sequencing data
- (2017) Julian R. de Ruiter et al. NUCLEIC ACIDS RESEARCH
- PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies
- (2017) Petr Smirnov et al. NUCLEIC ACIDS RESEARCH
- Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma
- (2017) Apinya Jusakul et al. Cancer Discovery
- Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical setting
- (2016) J. He et al. BLOOD
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- c-Myc Alteration Determines the Therapeutic Response to FGFR Inhibitors
- (2016) Hongyan Liu et al. CLINICAL CANCER RESEARCH
- Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland
- (2016) Stefano Annunziato et al. GENES & DEVELOPMENT
- The MaxQuant computational platform for mass spectrometry-based shotgun proteomics
- (2016) Stefka Tyanova et al. Nature Protocols
- High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
- (2016) A. Pearson et al. Cancer Discovery
- PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma
- (2016) Mirjam C. Boelens et al. Cell Reports
- Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy
- (2016) S-M Kim et al. Oncogenesis
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
- (2015) Giovanni Ciriello et al. CELL
- Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan–Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors
- (2015) Josep Tabernero et al. JOURNAL OF CLINICAL ONCOLOGY
- Using the GEMM-ESC strategy to study gene function in mouse models
- (2015) Ivo J Huijbers et al. Nature Protocols
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
- (2015) Antonio Colaprico et al. NUCLEIC ACIDS RESEARCH
- Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
- (2015) Linda Henneman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset
- (2015) B. Seashore-Ludlow et al. Cancer Discovery
- The Molecular Signatures Database Hallmark Gene Set Collection
- (2015) Arthur Liberzon et al. Cell Systems
- DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly
- (2014) Ilari Scheinin et al. GENOME RESEARCH
- The Fibroblast Growth Factor Receptor Genetic Status as a Potential Predictor of the Sensitivity to CH5183284/Debio 1347, a Novel Selective FGFR Inhibitor
- (2014) Y. Nakanishi et al. MOLECULAR CANCER THERAPEUTICS
- FGFR2 Is Amplified in the NCI-H716 Colorectal Cancer Cell Line and Is Required for Growth and Survival
- (2014) Anjili Mathur et al. PLoS One
- Pten Loss Induces Autocrine FGF Signaling to Promote Skin Tumorigenesis
- (2014) Kristina Hertzler-Schaefer et al. Cell Reports
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- Proteome-wide Prediction of Self-interacting Proteins Based on Multiple Properties
- (2013) Zhongyang Liu et al. MOLECULAR & CELLULAR PROTEOMICS
- Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
- (2013) Garrett M Frampton et al. NATURE BIOTECHNOLOGY
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- RSK2 regulates endocytosis of FGF receptor 1 by phosphorylation on serine 789
- (2013) B Nadratowska-Wesolowska et al. ONCOGENE
- Identification of Targetable FGFR Gene Fusions in Diverse Cancers
- (2013) Yi-Mi Wu et al. Cancer Discovery
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction
- (2012) Jian Ye et al. BMC BIOINFORMATICS
- Inhibition of Basal FGF Receptor Signaling by Dimeric Grb2
- (2012) Chi-Chuan Lin et al. CELL
- Translating the Therapeutic Potential of AZD4547 in FGFR1-Amplified Non-Small Cell Lung Cancer through the Use of Patient-Derived Tumor Xenograft Models
- (2012) J. Zhang et al. CLINICAL CANCER RESEARCH
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- FGFR Genetic Alterations Predict for Sensitivity to NVP-BGJ398, a Selective Pan-FGFR Inhibitor
- (2012) V. Guagnano et al. Cancer Discovery
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice
- (2011) P. W. B. Derksen et al. Disease Models & Mechanisms
- Integrative genomics viewer
- (2011) James T Robinson et al. NATURE BIOTECHNOLOGY
- Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
- (2010) N Turner et al. ONCOGENE
- A scaling normalization method for differential expression analysis of RNA-seq data
- (2010) Mark D Robinson et al. GENOME BIOLOGY
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects
- (2009) Sara Ota et al. HUMAN MOLECULAR GENETICS
- The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy
- (2009) Eugenio Montini et al. JOURNAL OF CLINICAL INVESTIGATION
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
- (2009) Da Wei Huang et al. Nature Protocols
- Aberrant Receptor Internalization and Enhanced FRS2-dependent Signaling Contribute to the Transforming Activity of the Fibroblast Growth Factor Receptor 2 IIIb C3 Isoform
- (2008) Jiyoung Y. Cha et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
- (2008) Jürgen Cox et al. NATURE BIOTECHNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started